Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1967 4
1970 1
1972 1
1975 1
1976 2
1977 3
1978 8
1979 3
1980 4
1981 2
1982 5
1983 4
1984 3
1986 2
1988 3
1989 2
1990 4
1991 1
1992 3
1994 4
1995 2
1996 3
1997 3
1998 8
1999 8
2000 10
2001 15
2002 12
2003 10
2004 9
2005 13
2006 14
2007 9
2008 14
2009 33
2010 24
2011 17
2012 14
2013 22
2014 15
2015 21
2016 21
2017 24
2018 15
2019 18
2020 17
2021 19
2022 25
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

444 results

Results by year

Filters applied: . Clear all
Page 1
Comprehensive genomic diagnosis of inherited retinal and optical nerve disorders reveals hidden syndromes and personalized therapeutic options.
Diñeiro M, Capín R, Cifuentes GÁ, Fernández-Vega B, Villota E, Otero A, Santiago A, Pruneda PC, Castillo D, Viejo-Díaz M, Hernando I, Durán NS, Álvarez R, Lago CG, Ordóñez GR, Fernández-Vega Á, Cabanillas R, Cadiñanos J. Diñeiro M, et al. Among authors: duran ns. Acta Ophthalmol. 2020 Dec;98(8):e1034-e1048. doi: 10.1111/aos.14479. Epub 2020 Jun 1. Acta Ophthalmol. 2020. PMID: 32483926 Free PMC article.
Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial.
Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, Aykan AÇ, Çakal B, Bayram Z, Oğuz AE, Ertürk E, Yesin M, Gökdeniz T, Duran NE, Yıldız M, Esen AM. Özkan M, et al. Among authors: duran ne. Am Heart J. 2015 Aug;170(2):409-18. doi: 10.1016/j.ahj.2015.04.025. Epub 2015 May 2. Am Heart J. 2015. PMID: 26299240 Clinical Trial.
Silver nanoparticles in dentistry.
Noronha VT, Paula AJ, Durán G, Galembeck A, Cogo-Müller K, Franz-Montan M, Durán N. Noronha VT, et al. Among authors: duran n. Dent Mater. 2017 Oct;33(10):1110-1126. doi: 10.1016/j.dental.2017.07.002. Epub 2017 Aug 2. Dent Mater. 2017. PMID: 28779891 Review.
Nanobiotechnology of Carbon Dots: A Review.
Durán N, Simões MB, de Moraes ACM, Fávaro WJ, Seabra AB. Durán N, et al. J Biomed Nanotechnol. 2016 Jul;12(7):1323-47. doi: 10.1166/jbn.2016.2225. J Biomed Nanotechnol. 2016. PMID: 29336531 Review.
Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
Islan GA, Durán M, Cacicedo ML, Nakazato G, Kobayashi RKT, Martinez DST, Castro GR, Durán N. Islan GA, et al. Among authors: duran n. Acta Trop. 2017 Jun;170:16-42. doi: 10.1016/j.actatropica.2017.02.019. Epub 2017 Feb 21. Acta Trop. 2017. PMID: 28232069 Review.
Familial tularaemia.
Peker E, Ayaydin A, Duran N. Peker E, et al. Among authors: duran n. Indian J Med Microbiol. 2009 Jul-Sep;27(3):272-5. doi: 10.4103/0255-0857.53217. Indian J Med Microbiol. 2009. PMID: 19584516 Free article.
Graphene Oxide as Scaffolds for Stem Cells: An Overview.
Duran M, Luzo ACM, de Souza JG, Favaro WJ, Garcia P, Duran N. Duran M, et al. Among authors: duran n. Curr Mol Med. 2017;17(9):619-626. doi: 10.2174/1566524018666180308111915. Curr Mol Med. 2017. PMID: 29521226 Review.
Nanotoxicity of graphene and graphene oxide.
Seabra AB, Paula AJ, de Lima R, Alves OL, Durán N. Seabra AB, et al. Among authors: duran n. Chem Res Toxicol. 2014 Feb 17;27(2):159-68. doi: 10.1021/tx400385x. Epub 2014 Jan 14. Chem Res Toxicol. 2014. PMID: 24422439 Review.
444 results